BioCatalystWatch
JSPRWorkspace / JSPR / OverviewCompany library
Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc. (JSPR)

Website

Price
Market cap
Next catalystExpected Q4 2026Vensobafusp alfa — IgAN Stage 1 · Phase 2 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

Vensobafusp alfa

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Vensobafusp alfa

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Briquilimab

KIT (CD117/c-Kit)

Vensobafusp alfa

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

KP701

CD79B × CD32B

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Vensobafusp alfa

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

KP701

CD79B × CD32B

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Vensobafusp alfa

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Vensobafusp alfa

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Briquilimab

KIT (CD117/c-Kit)

Other pipelines

Briquilimab

KIT (CD117/c-Kit)

PreINDP1P2P3FilingApproved

Partner / License out

History / paused

Briquilimab

KIT (CD117/c-Kit)

PreINDP1P2P3FilingApproved
Briquilimab

KIT (CD117/c-Kit)

PreINDP1P2P3FilingApproved
Briquilimab

KIT (CD117/c-Kit)

PreINDP1P2P3FilingApproved
Briquilimab

KIT (CD117/c-Kit)

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Financing

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

JSPR PR & News

PR & News

JSPR SEC archive